Riverbend Wealth Management’s Astera Labs ALAB Stock Holding History

Riverbend Wealth Management’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$545K	Buy	+1,128	New	+$299K	0.27%	102

Other funds holding ALAB

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

VAM

Valliance Asset Management Central, Hong Kong $864M AUM 906.77% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

SIC

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

VWS

Virtus Wealth Solutions Cranford, New Jersey $735M AUM 209.29% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Riverbend Wealth Management's ALAB Position: Q2 2026 in Review

Riverbend Wealth Management opened a new position in Astera Labs (ALAB) in Q2 2026: 1,128 shares worth $545K. The stake represents 0.27% of the portfolio and ranks #102 among its holdings.

361 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Riverbend Wealth Management held 1,128 shares of Astera Labs worth $545K as of Q2 2026.
Astera Labs was a new Riverbend Wealth Management position in Q2 2026.
Astera Labs made up 0.27% of Riverbend Wealth Management's portfolio in Q2 2026, its #102 holding.
361 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Riverbend Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.